aspsirna0059 |
AGUGAAUCUGGAUGCAGAAU UCACUUAGACCUACGUCUUA |
NA |
NA |
NA |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0060 |
AAGUGAAUCUGGAUGCAGAA UUCACUUAGACCUACGUCUU |
20 |
83 |
-63 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0061 |
GAAGUGAAUCUGGAUGCAGA CUUCACUUAGACCUACGUCU |
42 |
90 |
-48 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0062 |
UGAAGUGAAUCUGGAUGCAG ACUUCACUUAGACCUACGUC |
28 |
64 |
-36 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0063 |
CUGAAGUGAAUCUGGAUGCA GACUUCACUUAGACCUACGU |
44 |
79 |
-35 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0064 |
UCUGAAGUGAAUCUGGAUGC AGACUUCACUUAGACCUACG |
9 |
16 |
-7 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0065 |
AGUGAUCAUCAUCACCUUG UCACUAGUAGUAGUGGAAC |
3 |
17 |
-14 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0066 |
CAGUGAUCAUCAUCACCUU GUCACUAGUAGUAGUGGAA |
36 |
63 |
-27 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0067 |
ACAGUGAUCAUCAUCACCU UGUCACUAGUAGUAGUGGA |
18 |
17 |
1 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0068 |
GACAGUGAUCAUCAUCACC CUGUCACUAGUAGUAGUGG |
0 |
3 |
-3 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0069 |
CGACAGUGAUCAUCAUCAC GCUGUCACUAGUAGUAGUG |
45 |
55 |
-10 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0070 |
AGUGAUCUUCAUCACCUUG UCACUAGAAGUAGUGGAAC |
10 |
16 |
-6 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0071 |
CAGUGAUCUUCAUCACCUU GUCACUAGAAGUAGUGGAA |
13 |
73 |
-60 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0072 |
ACAGUGAUCUUCAUCACCU UGUCACUAGAAGUAGUGGA |
7 |
43 |
-36 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0073 |
GACAGUGAUCUUCAUCACC CUGUCACUAGAAGUAGUGG |
2 |
0 |
2 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0074 |
CGACAGUGAUCUUCAUCAC GCUGUCACUAGAAGUAGUG |
14 |
60 |
-46 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0075 |
GUGAUCGGCAUCACCUUGG CACUAGCCGUAGUGGAACC |
12 |
8 |
4 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0076 |
AGUGAUCGGCAUCACCUUG UCACUAGCCGUAGUGGAAC |
10 |
20 |
-10 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0077 |
CAGUGAUCGGCAUCACCUU GUCACUAGCCGUAGUGGAA |
45 |
35 |
10 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0078 |
ACAGUGAUCGGCAUCACCU UGUCACUAGCCGUAGUGGA |
16 |
4 |
12 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0079 |
GACAGUGAUCGGCAUCACC CUGUCACUAGCCGUAGUGG |
18 |
1 |
17 |
Amyloid beta (A4) precursor protein(APP) |
Alzheimers disease |
|
19771217 |
aspsirna0080 |
ACAAGCUGAGUAAGCCAAA UGUUCGACUCAUUCGGUUU |
55 |
95 |
-40 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0081 |
AACAAGCUGAGUAAGCCAA UUGUUCGACUCAUUCGGUU |
38 |
90 |
-52 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0082 |
UGGAACAAGCUGAGUAAGC ACCUUGUUCGACUCAUUCG |
20 |
-23 |
43 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0083 |
GUGGAACAAGCUGAGUAAG CACCUUGUUCGACUCAUUC |
52 |
82 |
-30 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0084 |
GUAAGCUAAAAACCAACAU CAUUCGAUUUUUGGUUGUA |
57 |
88 |
-31 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0085 |
AGUAAGCUAAAAACCAACA UCAUUCGAUUUUUGGUUGU |
60 |
63 |
-3 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0086 |
GAGUAAGCUAAAAACCAAC CUCAUUCGAUUUUUGGUUG |
27 |
96 |
-69 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0087 |
CCGAGUAAGCUAAAAACCA GGCUCAUUCGAUUUUUGGU |
84 |
92 |
-8 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0088 |
GCCGAGUAAGCUAAAAACC CGGCUCAUUCGAUUUUUGG |
74 |
87 |
-13 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0089 |
GUGCACAACUGCGUCAAUA CACGUGUUGACGCAGUUAU |
82 |
95 |
-13 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0090 |
UGUGCACAACUGCGUCAAU ACACGUGUUGACGCAGUUA |
88 |
70 |
18 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0091 |
UUUGUGCACAACUGCGUCA AAACACGUGUUGACGCAGU |
65 |
90 |
-25 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0092 |
CUUUGUGCACAACUGCGUC GAAACACGUGUUGACGCAG |
75 |
92 |
-17 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0093 |
ACUUUGUGCACAACUGCGU UGAAACACGUGUUGACGCA |
82 |
93 |
-11 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0133 |
GAACAAGCUGAGUAAGCCA CUUGUUCGACUCAUUCGGU |
90 |
99 |
-9 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0134 |
GAACUAGCUGAGUAAGCCA CUUGAUCGACUCAUUCGGU |
98 |
90 |
8 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0135 |
GAACAUGCUGAGUAAGCCA CUUGUACGACUCAUUCGGU |
85 |
98 |
-13 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0136 |
GAACAACCUGAGUAAGCCA CUUGUUGGACUCAUUCGGU |
86 |
98 |
-12 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0137 |
GAACAAGCUGACUAAGCCA CUUGUUCGACUGAUUCGGU |
92 |
98 |
-6 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0138 |
GAACAAGCUGAGAAAGCCA CUUGUUCGACUCUUUCGGU |
99 |
80 |
19 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0139 |
GAACAAGCUGAGUUAGCCA CUUGUUCGACUCAAUCGGU |
96 |
98 |
-2 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0140 |
GAACAAGCUGAGUAUGCCA CUUGUUCGACUCAUACGGU |
97 |
98 |
-1 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0141 |
GAACAAGCUGAGUAACCCA CUUGUUCGACUCAUUGGGU |
87 |
98 |
-11 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0142 |
GAACAAGCUGAGUAAGGCA CUUGUUCGACUCAUUCCGU |
95 |
98 |
-3 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0143 |
CGAGUAAGCUAAAAACCAA GCUCAUUCGAUUUUUGGUU |
86 |
98 |
-12 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0144 |
CGAGAAAGCUAAAAACCAA GCUCUUUCGAUUUUUGGUU |
87 |
99 |
-12 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0145 |
CGAGUUAGCUAAAAACCAA GCUCAAUCGAUUUUUGGUU |
84 |
99 |
-15 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0146 |
CGAGUAACCUAAAAACCAA GCUCAUUGGAUUUUUGGUU |
79 |
99 |
-20 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0147 |
CGAGUAAGCUAUAAACCAA GCUCAUUCGAUAUUUGGUU |
67 |
99 |
-32 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0148 |
CGAGUAAGCUAAUAACCAA GCUCAUUCGAUUAUUGGUU |
20 |
99 |
-79 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0149 |
CGAGUAAGCUAAAUACCAA GCUCAUUCGAUUUAUGGUU |
82 |
99 |
-17 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0150 |
CGAGUAAGCUAAAAUCCAA GCUCAUUCGAUUUUAGGUU |
36 |
99 |
-63 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0151 |
CGAGUAAGCUAAAAAGCAA GCUCAUUCGAUUUUUCGUU |
39 |
99 |
-60 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0152 |
CGAGUAAGCUAAAAACGAA GCUCAUUCGAUUUUUGCUU |
0 |
99 |
-99 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0153 |
GGAACAACCUGAGUAAGCC CCUUGUUGGACUCAUUCGG |
0 |
90 |
-90 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0154 |
GGAACAAGCUGUGUAAGCC CCUUGUUCGACACAUUCGG |
70 |
90 |
-20 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0155 |
GGAACAAGCUGACUAAGCC CCUUGUUCGACUGAUUCGG |
30 |
90 |
-60 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0156 |
GGAACAAGCUGAGAAAGCC CCUUGUUCGACUCUUUCGG |
94 |
90 |
4 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0157 |
GGAACAAGCUGAGUUAGCC CCUUGUUCGACUCAAUCGG |
50 |
90 |
-40 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0158 |
GGAACAAGCUGAGUAUGCC CCUUGUUCGACUCAUACGG |
90 |
90 |
0 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0159 |
GGAACAAGCUGAGUAACCC CCUUGUUCGACUCAUUGGG |
55 |
90 |
-35 |
Human prion protein (PRNP) |
Prion disease/Gerstmann-Straussler disease |
|
18493311 |
aspsirna0160 |
UUGUGCACAACUGCGUCAA AACACGUGUUGACGCAGUU |
70 |
89 |
-19 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0161 |
UUGUCCACAACUGCGUCAA AACAGGUGUUGACGCAGUU |
90 |
88 |
2 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0162 |
UUGUGGACAACUGCGUCAA AACACCUGUUGACGCAGUU |
52 |
88 |
-36 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0163 |
UUGUGCACAACAGCGUCAA AACACGUGUUGUCGCAGUU |
70 |
88 |
-18 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0164 |
UUGUGCACAACUCCGUCAA AACACGUGUUGAGGCAGUU |
22 |
88 |
-66 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0165 |
UUGUGCACAACUGGGUCAA AACACGUGUUGACCCAGUU |
78 |
88 |
-10 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0166 |
UUGUGCACAACUGCCUCAA AACACGUGUUGACGGAGUU |
60 |
88 |
-28 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0167 |
UUGUGCACAACUGCGACAA AACACGUGUUGACGCUGUU |
90 |
88 |
2 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0168 |
UUGUGCACAACUGCGUGAA AACACGUGUUGACGCACUU |
12 |
88 |
-76 |
Human prion protein (PRNP) |
Prion disease/Creutzfeldt-Jakob disease |
|
18493311 |
aspsirna0367 |
AGUGGCUCACCAGAUUACA UCACCGAGUGGUCUAAUGU |
60 |
30 |
30 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0368 |
AGUGGCUCACCUGAUUACA UCACCGAGUGGACUAAUGU |
80 |
17 |
63 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0369 |
AGUGGCUCACCACAUUACA UCACCGAGUGGUGUAAUGU |
85 |
25 |
60 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0370 |
AGUGGCUCACCAGUUUACA UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0371 |
AGUGGCUCACCAGGUUACA UCACCGAGUGGUCCAAUGU |
NA |
0 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0372 |
AGUGGCUCACCAGCUUACA UCACCGAGUGGUCGAAUGU |
98 |
40 |
58 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0373 |
AGUGGCUCACCAGAAUACA UCACCGAGUGGUCUUAUGU |
NA |
39 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0374 |
AGUGGCUCACCAGAUAACA UCACCGAGUGGUCUAUUGU |
NA |
22 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0375 |
AGUGGCUCACCAGAUUUCA UCACCGAGUGGUCUAAAGU |
NA |
70 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0376 |
CAGUGGCUCACCAGAUUAC GUCACCGAGUGGUCUAAUG |
NA |
NA |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0377 |
CAGUGGCUCACCUGAUUAC GUCACCGAGUGGACUAAUG |
NA |
40 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0378 |
CAGUGGCUCACCACAUUAC GUCACCGAGUGGUGUAAUG |
58 |
47 |
11 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0379 |
CAGUGGCUCACCAGUUUAC GUCACCGAGUGGUCAAAUG |
63 |
8 |
55 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0380 |
AGAUUUGGACCUGGCAGUC UCUAAACCUGGACCGUCAG |
NA |
NA |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0381 |
AGAUUUGGACCAGGCAGUC UCUAAACCUGGUCCGUCAG |
NA |
0 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0382 |
AGAUUUGGACCUCGCAGUC UCUAAACCUGGAGCGUCAG |
NA |
12 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0383 |
AGAUUUGGACCUGCCAGUC UCUAAACCUGGACGGUCAG |
5 |
16 |
-11 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0384 |
AGAUUUGGACCUGGGAGUC UCUAAACCUGGACCCUCAG |
35 |
65 |
-30 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0385 |
CAGAUUUGGACCUGGCAGU GUCUAAACCUGGACCGUCA |
69 |
38 |
31 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0386 |
CAGAUUUGGACGUGGCAGU GUCUAAACCUGCACCGUCA |
48 |
20 |
28 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0387 |
CAGAUUUGGACCAGGCAGU GUCUAAACCUGGUCCGUCA |
35 |
30 |
5 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0388 |
CAGAUUUGGACCUCGCAGU GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0389 |
CAGAUUUGGACCUGCCAGU GUCUAAACCUGGACGGUCA |
70 |
0 |
70 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0390 |
CAGAUUUGGACCUGGGAGU GUCUAAACCUGGACCCUCA |
92 |
30 |
62 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0391 |
CAGAUUUGGACCUGGCUGU GUCUAAACCUGGACCGACA |
5 |
26 |
-21 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0392 |
AGUGGCUCACCAGUUUACACUU UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0393 |
AGUGGCUCACCAGUUUACAC UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0394 |
AGUGGCUCACCAGUUUAC UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0395 |
CAGUGGCUCACCAGUUUAC UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0396 |
GUGGCUCACCAGUUUACA UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0397 |
GUGGCUCACCAGUUUACAC UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0398 |
CAGUGGCUCACCAGUUUACA UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0399 |
ACAGUGGCUCACCAGUUUACA UCACCGAGUGGUCAAAUGU |
NA |
13 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0400 |
CAGAUUUGGACCUCGCAGUCAU GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0401 |
CAGAUUUGGACCUCGCAGUC GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0402 |
CAGAUUUGGACCUCGCAG GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0403 |
GCAGAUUUGGACCUCGCAG GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0404 |
AGAUUUGGACCUCGCAGU GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0405 |
AGAUUUGGACCUCGCAGUC GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0406 |
GCAGAUUUGGACCUCGCAGU GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0407 |
AGCAGAUUUGGACCUCGCAGU GUCUAAACCUGGAGCGUCA |
50 |
32 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0408 |
AGAUUUGGACCUCGCAGUCAU UCUAAACCUGGAGCGUCAG |
NA |
12 |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0409 |
AGAUUUGGACCUCGCAGUUUA UCUAAACCUGGAGCGUCAG |
18 |
0 |
18 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0410 |
AGAUUUGGACCUCGCAGU UCUAAACCUGGAGCGUCAG |
21 |
0 |
21 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0411 |
GAUUUGGACCUCGCAGUC UCUAAACCUGGAGCGUCAG |
40 |
20 |
20 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0412 |
CAGAUUUGGACCUCGCAGUC UCUAAACCUGGAGCGUCAG |
45 |
18 |
27 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0413 |
GCAGAUUUGGACCUCGCAGUC UCUAAACCUGGAGCGUCAG |
8 |
56 |
-48 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0414 |
CAGAUUUGGACCUGGCAGUCA GUCUAAACCUGGACCGUCA |
10 |
52 |
-42 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0415 |
CAGAUUUGGACCUGGCAGUUC GUCUAAACCUGGACCGUCA |
33 |
42 |
-9 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0416 |
CAGAUUUGGACCUGGCAG GUCUAAACCUGGACCGUCA |
67 |
69 |
-2 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0417 |
GCAGAUUUGGACCUGGCAGU GUCUAAACCUGGACCGUCA |
60 |
0 |
60 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0418 |
AGAUUUGGACCUGGCAGU GUCUAAACCUGGACCGUCA |
0 |
6 |
-6 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0419 |
AGAUUUGGACCUGGCAGUC GUCUAAACCUGGACCGUCA |
26 |
74 |
-48 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0420 |
GCAGAUUUGGACCUGGCAGU GUCUAAACCUGGACCGUCA |
0 |
72 |
-72 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0421 |
AGCAGAUUUGGACCUGGCAGU GUCUAAACCUGGACCGUCA |
54 |
40 |
14 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0422 |
AGAUUUGGACCUGGCAGUCAU UCUAAACCUGGACCGUCAG |
NA |
NA |
NA |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0423 |
AGAUUUGGACCUGGCAGUCA UCUAAACCUGGACCGUCAG |
52 |
0 |
52 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0424 |
AGAUUUGGACCUGGCAGU UCUAAACCUGGACCGUCAG |
0 |
0 |
0 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0425 |
GAUUUGGACCUGGCAGUC UCUAAACCUGGACCGUCAG |
82 |
42 |
40 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0426 |
CAGAUUUGGACCUGGCAGUC UCUAAACCUGGACCGUCAG |
85 |
48 |
37 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0427 |
GCAGAUUUGGACCUGGCAGUC UCUAAACCUGGACCGUCAG |
75 |
72 |
3 |
Activin A receptor type I (ACVR1) |
Fibrodysplasia Ossificans Progressiva (FOP) |
|
22130450 |
aspsirna0428 |
GUGGUUGGUAAAGCCUCAG CACCAACCAUUUCGGAGUC |
63 |
93 |
-30 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0429 |
UGUGGUUGGUAAAGCCUCA ACACCAACCAUUUCGGAGU |
53 |
8 |
45 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0430 |
UUGUGGUUGGUAAAGCCUC AACACCAACCAUUUCGGAG |
54 |
28 |
26 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0431 |
GUUGUGGUUGGUAAAGCCU CAACACCAACCAUUUCGGA |
72 |
28 |
44 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0432 |
UGUUGUGGUUGGUAAAGCC ACAACACCAACCAUUUCGG |
38 |
14 |
24 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0433 |
GUGUUGUGGUUGGUAAAGC CACAACACCAACCAUUUCG |
90 |
15 |
75 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0434 |
AGUGUUGUGGUUGGUAAAG UCACAACACCAACCAUUUC |
73 |
40 |
33 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0435 |
CAGUGUUGUGGUUGGUAAA GUCACAACACCAACCAUUU |
69 |
29 |
40 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0436 |
ACAGUGUUGUGGUUGGUAA UGUCACAACACCAACCAUU |
63 |
17 |
46 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0437 |
UACAGUGUUGUGGUUGGUA AUGUCACAACACCAACCAU |
65 |
7 |
58 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0438 |
CUACAGUGUUGUGGUUGGU GAUGUCACAACACCAACCA |
0 |
0 |
0 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0439 |
UCUACAGUGUUGUGGUUGG AGAUGUCACAACACCAACC |
0 |
0 |
0 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0440 |
UUCUACAGUGUUGUGGUUG AAGAUGUCACAACACCAAC |
37 |
0 |
37 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0441 |
UUUCUACAGUGUUGUGGUU AAAGAUGUCACAACACCAA |
15 |
0 |
15 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0442 |
UUUUCUACAGUGUUGUGGU AAAAGAUGUCACAACACCA |
83 |
0 |
83 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0443 |
AUUUUCUACAGUGUUGUGG UAAAAGAUGUCACAACACC |
6 |
0 |
6 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0444 |
CAUUUUCUACAGUGUUGUG GUAAAAGAUGUCACAACAC |
82 |
0 |
82 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0445 |
UCAUUUUCUACAGUGUUGU AGUAAAAGAUGUCACAACA |
80 |
22 |
58 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0446 |
UUCAUUUUCUACAGUGUUG AAGUAAAAGAUGUCACAAC |
70 |
0 |
70 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
21559198 |
aspsirna0523 |
AAUGUUGGAGGAGCAGUGGUG UUACAACCUCCUCGUCACCAC |
NA |
NA |
NA |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0524 |
AAGGACCAGUUGGGCAAGAAU UUCCUGGUCAACCCGUUCUUA |
NA |
NA |
NA |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0525 |
AUGGUGUGACAACAGUGGCUG UACCACACUGUUGUCACCGAC |
39 |
20 |
19 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0526 |
CAUGGUGUGACAACAGUGGCU GUACCACACUGUUGUCACCGA |
45 |
70 |
-25 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0527 |
GCAUGGUGUGACAACAGUGGC CGUACCACACUGUUGUCACCG |
10 |
50 |
-40 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0528 |
AUGGUGUGAGAACAGUGGCUG UACCACACUCUUGUCACCGAC |
75 |
60 |
15 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0529 |
AUGGUGUGACAUCAGUGGCUG UACCACACUGUAGUCACCGAC |
51 |
2 |
49 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
16455076 |
aspsirna0744 |
AGGCAUGUUGGAGACUUGC UCCGUACAACCUCUGAACG |
88 |
88 |
0 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0745 |
GGCAUGUUGGAGACUUGCG CCGUACAACCUCUGAACGC |
88 |
74 |
14 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0746 |
GCAUGUUGGAGACUUGCGC CGUACAACCUCUGAACGCG |
92 |
38 |
54 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0747 |
CAUGUUGGAGACUUGCGCA GUACAACCUCUGAACGCGU |
94 |
90 |
4 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0748 |
AUGUUGGAGACUUGCGCAA UACAACCUCUGAACGCGUU |
95 |
60 |
35 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0749 |
UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
90 |
62 |
28 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0750 |
GUUGGAGACUUGCGCAAUG CAACCUCUGAACGCGUUAC |
94 |
92 |
2 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0751 |
UUGGAGACUUGCGCAAUGU AACCUCUGAACGCGUUACA |
81 |
55 |
26 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0752 |
UGGAGACUUGCGCAAUGUG ACCUCUGAACGCGUUACAC |
84 |
65 |
19 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0753 |
GGAGACUUGCGCAAUGUGA CCUCUGAACGCGUUACACU |
90 |
58 |
32 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0754 |
GAGACUUGCGCAAUGUGAC CUCUGAACGCGUUACACUG |
76 |
42 |
34 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0755 |
AGACUUGCGCAAUGUGACU UCUGAACGCGUUACACUGA |
85 |
56 |
29 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0756 |
GACUUGCGCAAUGUGACUG CUGAACGCGUUACACUGAC |
62 |
54 |
8 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0757 |
ACUUGCGCAAUGUGACUGC UGAACGCGUUACACUGACG |
72 |
47 |
25 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0758 |
CUUGCGCAAUGUGACUGCU GAACGCGUUACACUGACGA |
80 |
79 |
1 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0759 |
UUGCGCAAUGUGACUGCUG AACGCGUUACACUGACGAC |
77 |
53 |
24 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0760 |
UGCGCAAUGUGACUGCUGA ACGCGUUACACUGACGACU |
84 |
87 |
-3 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0761 |
GCGCAAUGUGACUGCUGAC CGCGUUACACUGACGACUG |
70 |
77 |
-7 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0762 |
CGCAAUGUGACUGCUGACA GCGUUACACUGACGACUGU |
83 |
87 |
-4 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
16965178 |
aspsirna0806 |
CGGAGCCUUUGGAAGUCUGUA GCCUCGGAAACCUUCAGACAU |
78 |
22 |
56 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0807 |
GGAGCCUUUGGAAGUCUGUGA CCUCGGAAACCUUCAGACACU |
65 |
47 |
18 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0808 |
GAGCCUUUGGAAGUCUGUGCA CUCGGAAACCUUCAGACACGU |
68 |
34 |
34 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0809 |
AGCCUUUGGAAGUCUGUGCCA UCGGAAACCUUCAGACACGGU |
88 |
61 |
27 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0810 |
GCCUUUGGAAGUCUGUGCCCA CGGAAACCUUCAGACACGGGU |
60 |
32 |
28 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0811 |
CCUUUGGAAGUCUGUGCCCUA GGAAACCUUCAGACACGGGAU |
62 |
43 |
19 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0812 |
CUUUGGAAGUCUGUGCCCUUA GAAACCUUCAGACACGGGAAU |
92 |
77 |
15 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0813 |
UUUGGAAGUCUGUGCCCUUGA AAACCUUCAGACACGGGAACU |
55 |
38 |
17 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0814 |
UUGGAAGUCUGCGCCCUUGUG AACCUUCAGACGCGGGAACAC |
70 |
20 |
50 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0815 |
UUGGAAGUCUGUGCCCUUGUA AACCUUCAGACACGGGAACAU |
65 |
15 |
50 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0816 |
UUGGAAGUCUGUGCCCUUGCG AACCUUCAGACACGGGAACGC |
69 |
15 |
54 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0817 |
UUGGAAGUCUGUGCCCUUAUG AACCUUCAGACACGGGAAUAC |
70 |
20 |
50 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0818 |
UUGGAAGUCUGUGCCCUGGUG AACCUUCAGACACGGGACCAC |
34 |
23 |
11 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0819 |
UUGGAAGUCUGUGCCCGUGUG AACCUUCAGACACGGGCACAC |
54 |
25 |
29 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0820 |
UUGGAAGUCUGUGCCAUUGUG AACCUUCAGACACGGUAACAC |
57 |
30 |
27 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0821 |
UUGGAAGUCUGUGCACUUGUG AACCUUCAGACACGUGAACAC |
80 |
50 |
30 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0822 |
UUGGAAGUCUGUGCCAUUGUG AACCUUCAGACACGGUAACAC |
70 |
45 |
25 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0823 |
GAAGUCUGUGCCCUUGUGCCA CUUCAGACACGGGAACACGGU |
65 |
20 |
45 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0824 |
GUCUGUGCCCUUGUGCCCUGC CAGACACGGGAACACGGGACG |
58 |
37 |
21 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0825 |
GUCUGUGCCCUUGUGCCCUAC CAGACACGGGAACACGGGAUG |
58 |
37 |
21 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0826 |
GUCUGUGCCCUUGUGCCCGGC CAGACACGGGAACACGGGCCG |
43 |
12 |
31 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0827 |
GUCUGUGCCCUUGUGCCAUGC CAGACACGGGAACACGGUACG |
55 |
36 |
19 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0828 |
GUCUGUGCCCUUGUGCACUGC CAGACACGGGAACACGUGACG |
55 |
43 |
12 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0829 |
GUCUGUGCCCUUGUGACCUGC CAGACACGGGAACACUGGACG |
46 |
30 |
16 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0830 |
GUCUGUGCCCUUGUACCCUGC CAGACACGGGAACAUGGGACG |
80 |
50 |
30 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0831 |
GUCUGUUCCCUUGUGCCCUGC CAGACAAGGGAACACGGGACG |
54 |
41 |
13 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0832 |
GUCUGUACCCUUGUGCCCUGC CAGACAUGGGAACACGGGACG |
87 |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0833 |
GUCUAUGCCCUUGUGCCCUGC CAGAUACGGGAACACGGGACG |
76 |
16 |
60 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0834 |
GUCUUUGCCCUUGUGCCCUGC CAGAAACGGGAACACGGGACG |
86 |
42 |
44 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0835 |
GUCAUUGCCCUUGUGCCCUGC CAGUAACGGGAACACGGGACG |
86 |
42 |
44 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0836 |
AGUCUAUGCCCUUGUGCCCUG UCAGAUACGGGAACACGGGAC |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0837 |
UGGGGACAGUACUUCAACGCU ACCCCUGUCAUGAAGUUGCGA |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0838 |
UGGGGACAGUAAUUCAACGCU ACCCCUGUCAUUAAGUUGCGA |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0839 |
CAGUACUUCAACGCUAGAAGA GUCAUGAAGUUGCGAUCUUCU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0840 |
CAGUAAUUCAACGCUAGAAGA GUCAUUAAGUUGCGAUCUUCU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0841 |
AAGCUGCUGCUACAGAUCAAC UUCGACGACGAUGUCUAGUUG |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0842 |
AAGCUGCUGCUGCAGAUCAAC UUCGACGACGACGUCUAGUUG |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0843 |
CUGCUACAGAUCAACCCCGAG GACGAUGUCUAGUUGGGGCUC |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0844 |
CUGCUGCAGAUCAACCCCGAG GACGACGUCUAGUUGGGGCUC |
23 |
9 |
14 |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0845 |
AAGCUGCUGCUACAGAUCAGA UUCGACGACGAUGUCUAGUCU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0846 |
AAGCUGCUGCUACAGAUCGAA UUCGACGACGAUGUCUAGCUU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0847 |
AAGCUGCUGCUACAGAUAAAA UUCGACGACGAUGUCUAUUUU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0848 |
AAGCUGCUGCUACAGAGCAAA UUCGACGACGAUGUCUCGUUU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0849 |
AAGCUGCUGCUACAGGUCAAA UUCGACGACGAUGUCCAGUUU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0850 |
AAGCUGCUGCUACAAAUCAAA UUCGACGACGAUGUUUAGUUU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0851 |
AAGCUGCUGCUGCAGAGCAAA UUCGACGACGACGUCUCGUUU |
NA |
NA |
NA |
Hungtintin (HTT) |
Huntington disease (HD) |
|
19361997 |
aspsirna0872 |
GUCCCGGCAGGUGGUGGAGC CAGGGCCGUCCACCACCUCG |
60 |
15 |
45 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
18776243 |
aspsirna0873 |
GACCCGGCAGGUGGUGGAGCA CUGGGCCGUCCACCACCUCGU |
70 |
20 |
50 |
Presenilin1 (PSEN1) |
Alzheimers disease |
|
18776243 |
aspsirna0911 |
CACACGGAAUGUGAUGGCC GUGUGCCUUACACUACCGG |
NA |
NA |
NA |
MHC, class I, A (HLA-A) heavy chain |
HLA incompatibility |
|
16520945 |
aspsirna0912 |
GAGCUCAGAUAGAAAAGGU CUCGAGUCUAUCUUUUCCA |
30 |
NA |
NA |
MHC, class I, A (HLA-A) heavy chain |
HLA incompatibility |
|
16520945 |
aspsirna0913 |
AAGGAGGGAGCUUCUCUCA UUCCUCCCUCGAAGAGAGU |
35 |
NA |
NA |
MHC, class I, A (HLA-A) heavy chain |
HLA incompatibility |
|
16520945 |
aspsirna0914 |
AGAUACUCCUGCCAUGUGC UCUAUGAGGACGGUACACG |
75 |
NA |
NA |
MHC, class I, A (HLA-A) heavy chain |
HLA incompatibility |
|
16520945 |
aspsirna0915 |
UGAUACACCUGCCAUGUGC ACUAUGUGGACGGUACACG |
80 |
NA |
NA |
MHC, class I, A (HLA-A) heavy chain |
HLA incompatibility |
|
16520945 |
aspsirna0916 |
AAAGUGGAGCAUUCACACU UUUCACCUCGUAAGUGUGA |
89 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0917 |
GAUGAGUAUGCCUGCCGUC CUACUCAUACGGACGGCAG |
93 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0918 |
UCCAUCCGACAUUGAACUU AGGUAGGCUGUAACUUGAA |
75 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0919 |
UUCGAAGCUUGAAGCUAA AAGCUUCGAACUUCGAUU |
88 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0920 |
GGUUUACUCACCUCAUCCA CCAAAUGAGUGGAGUAGGU |
70 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0921 |
GUGGGAUCGAGACAUCUAA CACCCUAGCUCUGUAGAUU |
80 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0922 |
GUGGGAUCGAGACAUCUAA CACCCUAGCUCUGUAGAUU |
45 |
NA |
NA |
Beta 2-microglobulin (B2M) |
HLA incompatibility |
|
16520945 |
aspsirna0932 |
CUGCUGACAAAGAUGCUGU GACGACUGUUUCUACGACA |
85 |
90 |
-5 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
14981234 |
aspsirna0933 |
CAAAGAUGCUGUGGCCGAU GUUUCUACGACACCGGCUA |
78 |
65 |
13 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
14981234 |
aspsirna0934 |
CAAAGAUGCUGUGGCCGAU GUUUCUACGACACCGGCUA |
80 |
34 |
46 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
14981234 |
aspsirna0937 |
AUGACGACGCUGGUAUAGG UACUGCUGCGACCAUAUCC |
73 |
33 |
40 |
Androgen receptor (AR) |
Spinal and Bulbar Muscular Atrophy, X-linked 1; SMAX1/Kennedy’s disease |
|
11809726 |
aspsirna1006 |
UGGAGACUUGCGCAAUGUG ACCUCUGAACGCGUUACAC |
95 |
Lowest effective |
High discrimination |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
12934714 |
aspsirna1007 |
GGAGACUUGCGCAAUGUGA CCUCUGAACGCGUUACACU |
80 |
Lowest effective |
High discrimination |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
12934714 |
aspsirna1008 |
GAGACUUGCGCAAUGUGAC CUCUGAACGCGUUACACUG |
96 |
Poor efficacy |
High discrimination |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
12934714 |
aspsirna1009 |
UGGAGACUUGGGCAAUGUG ACCUCUGAACCCGUUACAC |
82 |
Poor efficacy |
High discrimination |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
12934714 |
aspsirna1010 |
GGAGACUUGGGCAAUGUGA CCUCUGAACCCGUUACACU |
20 |
46 |
-26 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
12934714 |
aspsirna1011 |
GAGACUUGGGCAAUGUGAC CUCUGAACCCGUUACACUG |
NA |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
12934714 |
aspsirna1746 |
UGACUCCUGAGGAGAAGUU ACUGAGGACUCCUCUUCAG |
NA |
65 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1747 |
UGACUCCUGAGGAGAAGUG ACUGAGGACUCCUCUUCAG |
NA |
12 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1748 |
UGACUCCUGAGGAGAAGUG ACUGAGGACUCCUCUUCAC |
NA |
25 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1749 |
UGACUCCUGAGGAGAAGUC ACUGAGGACUCCUCUUCAG |
NA |
10 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1750 |
UGACUCCUGUGGAGAAGUC ACUGAGGACACCUCUUCAG |
NA |
10 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1751 |
UGACUCCUGUGGAGAAGUU ACUGAGGACACCUCUUCAG |
NA |
5 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1752 |
UGACUCCUGUGGAGAAGUG ACUGAGGACACCUCUUCAG |
NA |
10 |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1753 |
UGACUCCUGUGGAGAAGUG ACUGAGGACACCUCUUCAC |
NA |
NA |
NA |
Hb beta-chain (HBB) |
Sickle cell anemia |
|
16585504 |
aspsirna1754 |
GGAAGACGCCAAAAACAUA CCUUCUGCGGUUUUUGUAU |
NA |
98 |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1755 |
GGAAGACGCCAAAAACAUU CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1756 |
GGAAGACGCCAAAAACAAU CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1757 |
GGAAGACGCCAAAAACUAU CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1758 |
GGAAGACGCCAAAAAUUAU CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1759 |
UUAAGACGCCAAAAACAUA CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1760 |
GGAAGACGCCAAAAACAAU CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1761 |
GGAAGACGCCAAAAACAUA CCUUCUGCGGUUUUUGUAU |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1762 |
ACCGCUGGAGAGCAACUGC UGGCGACCUCUCGUUGACG |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1763 |
ACCGCUGGAGAGCAACUGU UGGCGACCUCUCGUUGACG |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1764 |
ACCGCUGGAGAGCAACUUU UGGCGACCUCUCGUUGACG |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1765 |
ACCGCUGGAGAGCAACAUU UGGCGACCUCUCGUUGACG |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1766 |
ACCGCUGGAGAGCAAUAUU UGGCGACCUCUCGUUGACG |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1767 |
UACGCUGGAGAGCAAUAUU AUGCGACCUCUCGUUGACG |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1768 |
UGCUGAGAGGAUCAGCAUU ACGACUCUCCUAGUCGUAA |
NA |
NA |
NA |
P. luciferase |
NA |
|
14741366 |
aspsirna1769 |
UGCUGAGAGGAACAGCAACCU AGACGACUCUCCUUGUCGUUG |
NA |
NA |
NA |
Human lamin A/C (LMNA) |
NA |
|
14741366 |
aspsirna1770 |
UGCUGAGUGGAACAGCAUU AGACGACUCUCCUUGUCGUUG |
NA |
NA |
NA |
Human lamin A/C (LMNA) |
NA |
|
14741366 |
aspsirna1771 |
CUGGACUUCCAGAAGAACA GACCUGAAGGUCUUCUUGU |
NA |
NA |
NA |
Human lamin A/C (LMNA) |
NA |
|
14741366 |
aspsirna1772 |
CUGGACUACCAGAAGAA GACCUGAAGGUCUUCGU |
NA |
NA |
NA |
Human lamin A/C (LMNA) |
NA |
|
14741366 |
aspsirna1773 |
GUCCGCAGGCGGCUCAAAGAUU CAGGCGUCCGCCGAGUUUCUAA |
NA |
NA |
NA |
DNA (cytosine-5-)-methyltransferase 1 (DNMT1) |
NA |
|
14741366 |
aspsirna1774 |
GUCCGCAGUCGGCUCAAAUU CAGGCGUCCGCCGAGUUUCU |
NA |
NA |
NA |
DNA (cytosine-5-)-methyltransferase 1 (DNMT1) |
NA |
|
14741366 |
aspsirna1775 |
GUGACUUGGAAACCAAAUU CACUGAACCUUUGGUUUAA |
NA |
NA |
NA |
DNA (cytosine-5-)-methyltransferase 1 (DNMT1) |
NA |
|
14741366 |
aspsirna1776 |
GUGACUUUGAAACCAAAAA CACUGAACCUUUGGUUUAA |
NA |
NA |
NA |
DNA (cytosine-5-)-methyltransferase 1 (DNMT1) |
NA |
|
14741366 |
aspsirna1817 |
AAGCAGCACAAUGAUGAGCGC UUCGUCGUGUUACUACUCGCG |
NA |
75 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1818 |
AAGCAGCACAAUGACGAGUGC UUCGUCGUGUUACUGCUCACG |
NA |
38 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1819 |
AAGCAGCACAACGAUGAGUGC UUCGUCGUGUUGCUACUCACG |
NA |
70 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1820 |
AAGCAGCACAAUGAUGAGUAC UUCGUCGUGUUACUACUCAUG |
NA |
60 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1821 |
AAGCAGCACAAUGAUAAGUGC UUCGUCGUGUUACUAUUCACG |
NA |
22 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1822 |
AAGCAGCACAAUAAUGAGUGC UUCGUCGUGUUAUUACUCACG |
NA |
23 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1823 |
AAGCAACACAAUGAUGAGUGC UUCGUUGUGUUACUACUCACG |
NA |
55 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1824 |
AAACAGCACAAUGAUGAGUGC UUUGUCGUGUUACUACUCACG |
NA |
75 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1825 |
AAGCAGCACAAUGACGAGCGC UUCGUCGUGUUACUGCUCGCG |
NA |
22 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1826 |
AAGCAGCACAACGACGAGUGC UUCGUCGUGUUGCUGCUCACG |
NA |
38 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1827 |
AAGCAGCACAAUGACGAGCAC UUCGUCGUGUUACUGCUCGUG |
NA |
22 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1828 |
AAGCAGCACAACGACGAGCGC UUCGUCGUGUUGCUGCUCGCG |
NA |
20 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1829 |
AAACAGCACAAUGACGAGCGC UUUGUCGUGUUACUGCUCGCG |
NA |
75 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1830 |
AAGCAGCACAAUGAUGAGUGU UUCGUCGUGUUACUACUCACA |
NA |
72 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1831 |
AAGCAGCACAAUGAUGAGUGG UUCGUCGUGUUACUACUCACC |
NA |
72 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1832 |
AAGCAGCACAAUGAUGAGUGA UUCGUCGUGUUACUACUCACU |
NA |
40 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1833 |
AAGCAGCACAAUGAUGAGGGC UUCGUCGUGUUACUACUCCCG |
NA |
55 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1834 |
AAGCAGCACAAUGAGGAGUGC UUCGUCGUGUUACUCCUCACG |
NA |
72 |
NA |
Flap structure-specific endonuclease 1 (Fen1) |
Werner syndrome |
|
16113241 |
aspsirna1835 |
CCCCCUACCUGUGGACAUGGU GGGGGAUGGACACCUGUACCA |
NA |
70 |
NA |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1836 |
UAUGUCCACAGGUAGGGGGUU AUACAGGUGUCCAUCCCCCAA |
NA |
25 |
NA |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1837 |
CCCCCUACCUGUGGACAUGGU GGGGGAUGGACACCUGUACCA |
NA |
32 |
NA |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1838 |
CCUCACUGCUGGCCAUGGACU GGAGUGACGACCGGUACCUGA |
NA |
29 |
NA |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1839 |
CCUCACUGCUGGCCAUGGGCU GGAGUGACGACCGGUACCCGA |
NA |
31 |
NA |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1840 |
CCUCACUGCUGGCCAUGGACU GGAGUGACGACCGGUACCUGA |
NA |
22 |
NA |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1841 |
UGGCCAUGGGCUCCUGGUAGA ACCGGUACCCGAGGACCAUCU |
10 |
42 |
-32 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1842 |
UGGCCAUGGGCUCCUGGUGGA ACCGGUACCCGAGGACCACCU |
80 |
30 |
50 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1843 |
UGGCCAUGGGCUCCUGGUAGA ACCGGUACCCGAGGACCAUCU |
23 |
50 |
-27 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1844 |
CCAGCAUGAAUCCAGCUCAAU GGUCGUACUUAGGUCGAGUUA |
15 |
65 |
-50 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1845 |
CCAGCAUGAAUCCAGCUCGAU GGUCGUACUUAGGUCGAGCUA |
5 |
55 |
-50 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1846 |
CCAGCAUGAAUCCAGCUCAAU GGUCGUACUUAGGUCGAGUUA |
60 |
40 |
20 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1847 |
AGUUAUCAUGGGAAACUGAGA UCAAUAGUACCCUUUGACUCU |
26 |
58 |
-32 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1848 |
AGUUAUCAUGGGAAACUGGGA UCAAUAGUACCCUUUGACCCU |
8 |
45 |
-37 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1849 |
AGUUAUCAUGGGAAACUGAGA UCAAUAGUACCCUUUGACUCU |
23 |
30 |
-7 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1850 |
CACUGGAUAUAUUGGGUUAGA GUGACCUAUAUAACCCAAUCU |
80 |
74 |
6 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1851 |
CACUGGAUAUAUUGGGUUGGA GUGACCUAUAUAACCCAACCU |
78 |
68 |
10 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1852 |
CACUGGAUAUAUUGGGUUAGA GUGACCUAUAUAACCCAAUCU |
22 |
52 |
-30 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1853 |
GGGAGCUACAUGGAGGUGAAG CCCUCGAUGUACCUCCACUUC |
80 |
55 |
25 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1854 |
GGGAGCUACAUGGAGGUGGAG CCCUCGAUGUACCUCCACCUC |
60 |
50 |
10 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1855 |
GGGAGCUACAUGGAGGUGAAG CCCUCGAUGUACCUCCACUUC |
50 |
52 |
-2 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1856 |
GACUUGAUCCUGAAGCCCAGG CUGAACUAGGACUUCGGGUCC |
70 |
83 |
-13 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1857 |
GACUUGAUCCUGAAGCCCGGG CUGAACUAGGACUUCGGGCCC |
60 |
76 |
-16 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1858 |
GACUUGAUCCUGAAGCCCAGG CUGAACUAGGACUUCGGGUCC |
10 |
90 |
-80 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1859 |
GGACUCGUCUGGAGAGGUAUU CCUGAGCAGACCUCUCCAUAA |
25 |
93 |
-68 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1860 |
GGACUCGUCUGGAGAGGUGUA CCUGAGCAGACCUCUCCACAU |
15 |
89 |
-74 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1861 |
GGACUCGUCUGGAGAGGUAUU CCUGAGCAGACCUCUCCAUAA |
50 |
88 |
-38 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1862 |
AACCGGAGCCAAGUGGAGCCA UUGGCCUCGGUUCACCUCGGU |
88 |
85 |
3 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1863 |
AACCGGAGCCAAGUGGAGACA UUGGCCUCGGUUCACCUCUGU |
93 |
82 |
11 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1864 |
AACCGGAGCCAAGUGGAGCCA UUGGCCUCGGUUCACCUCGGU |
70 |
15 |
55 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1865 |
UGGCCAUGGGCUCCUGGUAGA ACCGGUACCCGAGGACCAUCU |
10 |
42 |
-32 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1866 |
UGGCCAUGGGCUCCUGGUGGA ACCGGUACCCGAGGACCACCU |
80 |
30 |
50 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1867 |
UGGCCAUGGGCUCCUGGUAGA ACCGGUACCCGAGGACCAUCU |
23 |
50 |
-27 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1868 |
CCAGCAUGAAUCCAGCUCAAU GGUCGUACUUAGGUCGAGUUA |
15 |
65 |
-50 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1869 |
CCAGCAUGAAUCCAGCUCGAU GGUCGUACUUAGGUCGAGCUA |
5 |
55 |
-50 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1870 |
CCAGCAUGAAUCCAGCUCAAU GGUCGUACUUAGGUCGAGUUA |
60 |
40 |
20 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1871 |
AGUUAUCAUGGGAAACUGAGA UCAAUAGUACCCUUUGACUCU |
26 |
58 |
-32 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1872 |
AGUUAUCAUGGGAAACUGGGA UCAAUAGUACCCUUUGACCCU |
8 |
45 |
-37 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1873 |
AGUUAUCAUGGGAAACUGAGA UCAAUAGUACCCUUUGACUCU |
23 |
30 |
-7 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1874 |
CACUGGAUAUAUUGGGUUAGA GUGACCUAUAUAACCCAAUCU |
80 |
74 |
6 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1875 |
CACUGGAUAUAUUGGGUUGGA GUGACCUAUAUAACCCAACCU |
78 |
68 |
10 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1876 |
CACUGGAUAUAUUGGGUUAGA GUGACCUAUAUAACCCAAUCU |
22 |
52 |
-30 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1877 |
GGGAGCUACAUGGAGGUGAAG CCCUCGAUGUACCUCCACUUC |
80 |
55 |
25 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1878 |
GGGAGCUACAUGGAGGUGGAG CCCUCGAUGUACCUCCACCUC |
60 |
50 |
10 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1879 |
GGGAGCUACAUGGAGGUGAAG CCCUCGAUGUACCUCCACUUC |
50 |
52 |
-2 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1880 |
GACUUGAUCCUGAAGCCCAGG CUGAACUAGGACUUCGGGUCC |
70 |
83 |
-13 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1881 |
GACUUGAUCCUGAAGCCCGGG CUGAACUAGGACUUCGGGCCC |
60 |
76 |
-16 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1882 |
GACUUGAUCCUGAAGCCCAGG CUGAACUAGGACUUCGGGUCC |
10 |
90 |
-80 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1883 |
AACCGGAGCCAAGUGGAGCCA UUGGCCUCGGUUCACCUCGGU |
88 |
85 |
3 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1884 |
AACCGGAGCCAAGUGGAGACA UUGGCCUCGGUUCACCUCUGU |
93 |
82 |
11 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1885 |
AACCGGAGCCAAGUGGAGCCA UUGGCCUCGGUUCACCUCGGU |
70 |
15 |
55 |
Aquaporin 4 (Aqp4) |
Brain edema |
|
16113241 |
aspsirna1914 |
CGUCGCUAUCAAGGAA----------CAA GCAGCGAUAGUUCCUU----------GUU |
82 |
10 |
72 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1915 |
GUCGCUAUCAAGGAA----------CAAC CAGCGAUAGUUCCUU----------GUUG |
95 |
0 |
95 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1916 |
UCGCUAUCAAGGAA----------CAAC AGCGAUAGUUCCUU----------GUUG |
90 |
8 |
82 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1917 |
CGCUAUCAAGGAA----------CAACA GCGAUAGUUCCUU----------GUUGU |
95 |
38 |
57 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1918 |
GCUAUCAAGGAA----------CAACAU CGAUAGUUCCUU----------GUUGUA |
80 |
22 |
58 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1919 |
CUAUCAAGGAA----------CAACAUC GAUAGUUCCUU----------GUUGUAG |
93 |
8 |
85 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1920 |
UAUCAAGGAA----------CAACAUCU AUAGUUCCUU----------GUUGUAGA |
82 |
0 |
82 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1921 |
AUCAAGGAA----------CAACAUCUC UAGUUCCUU----------GUUGUAGAG |
70 |
0 |
70 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1922 |
UCAAGGAA----------CAACAUCUCC AGUUCCUU---GUUGUAGAGG |
60 |
5 |
55 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1923 |
CGUCGCUAUCAAGGAA----------CAA GCAGCGAUAGUUCCUU----------GUU |
82 |
10 |
72 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1924 |
GUCGCUAUCAAGGAA----------CAAC CAGCGAUAGUUCCUU----------GUUG |
95 |
0 |
95 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1925 |
UCGCUAUCAAGGAA----------CAAC AGCGAUAGUUCCUU----------GUUG |
90 |
8 |
82 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1926 |
CGCUAUCAAGGAA----------CAACA GCGAUAGUUCCUU----------GUUGU |
95 |
38 |
57 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1927 |
GCUAUCAAGGAA----------CAACAU CGAUAGUUCCUU----------GUUGUA |
80 |
22 |
58 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1928 |
CUAUCAAGGAA----------CAACAUC GAUAGUUCCUU----------GUUGUAG |
93 |
8 |
85 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1929 |
UAUCAAGGAA----------CAACAUCU AUAGUUCCUU----------GUUGUAGA |
82 |
0 |
82 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1930 |
AUCAAGGAA----------CAACAUCUC UAGUUCCUU----------GUUGUAGAG |
70 |
0 |
70 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1931 |
UCAAGGAA----------CAACAUCUCC AGUUCCUU---GUUGUAGAGG |
60 |
5 |
55 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1932 |
UCCCGUCGCUAUCAA---------------AACA AGGGCAGCGAUAGUU---------------UUGU |
95 |
3 |
92 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1933 |
CCGUCGCUAUCAA---------------AACAUC GGCAGCGAUAGUU---------------UUGUAG |
90 |
4 |
86 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1934 |
GUCGCUAUCAA---------------AACAUCUC CAGCGAUAGUU---------------UUGUAGAG |
95 |
10 |
85 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1935 |
CGCUAUCAA---------------AACAUCUCCG GCGAUAGUU---------------UUGUAGAGGC |
70 |
30 |
40 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1936 |
CUAUCAA---------------AACAUCUCCGAA GAUAGUU---------------UUGUAGAGGCUU |
97 |
33 |
64 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1937 |
AUCAA---------------AACAUCUCCGAAAG UAGUU---------------UUGUAGAGGCUUUC |
75 |
5 |
70 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1938 |
CAA---------------AACAUCUCCGAAAGCC GUU---------------UUGUAGAGGCUUUCGG |
70 |
30 |
40 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1939 |
UCCCGUCGCUAUCAA---------------AACA AGGGCAGCGAUAGUU---------------UUGU |
95 |
3 |
92 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1940 |
CCGUCGCUAUCAA---------------AACAUC GGCAGCGAUAGUU---------------UUGUAG |
90 |
4 |
86 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1941 |
GUCGCUAUCAA---------------AACAUCUC CAGCGAUAGUU---------------UUGUAGAG |
95 |
10 |
85 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1942 |
CGCUAUCAA---------------AACAUCUCCG GCGAUAGUU---------------UUGUAGAGGC |
70 |
30 |
40 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1943 |
CUAUCAA---------------AACAUCUCCGAA GAUAGUU---------------UUGUAGAGGCUU |
97 |
33 |
64 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1944 |
AUCAA---------------AACAUCUCCGAAAG UAGUU---------------UUGUAGAGGCUUUC |
75 |
5 |
70 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna1945 |
CAA---------------AACAUCUCCGAAAGCC GUU---------------UUGUAGAGGCUUUCGG |
70 |
30 |
40 |
epidermal growth factor receptor (EGFR) |
Cancer |
|
23951344 |
aspsirna2116 |
UUGUGGUAGUUGGAGCUGU AACACCAUCAACCUCGACA |
20 |
0 |
20 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2117 |
UGUGGUAGUUGGAGCUGUU ACACCAUCAACCUCGACAA |
20 |
5 |
15 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2118 |
GUGGUAGUUGGAGCUGUUG CACCAUCAACCUCGACAAC |
0 |
8 |
-8 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2119 |
UGGUAGUUGGAGCUGUUGG ACCAUCAACCUCGACAACC |
5 |
0 |
5 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2120 |
GGUAGUUGGAGCUGUUGGC CCAUCAACCUCGACAACCG |
0 |
25 |
-25 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2121 |
GUAGUUGGAGCUGUUGGCG CAUCAACCUCGACAACCGC |
3 |
0 |
3 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2122 |
UAGUUGGAGCUGUUGGCGU AUCAACCUCGACAACCGCA |
10 |
8 |
2 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2123 |
AGUUGGAGCUGUUGGCGUA UCAACCUCGACAACCGCAU |
75 |
70 |
5 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2124 |
GUUGGAGCUGUUGGCGUAG CAACCUCGACAACCGCAUC |
0 |
55 |
-55 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2125 |
UUGGAGCUGUUGGCGUAGG AACCUCGACAACCGCAUCC |
10 |
8 |
2 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2126 |
UGGAGCUGUUGGCGUAGGC ACCUCGACAACCGCAUCCG |
5 |
0 |
5 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2127 |
GGAGCUGUUGGCGUAGGCA CCUCGACAACCGCAUCCGU |
5 |
1 |
4 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2128 |
GAGCUGUUGGCGUAGGCAA CUCGACAACCGCAUCCGUU |
5 |
20 |
-15 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2129 |
AGCUGUUGGCGUAGGCAAG UCGACAACCGCAUCCGUUC |
10 |
33 |
-23 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2130 |
GCUGUUGGCGUAGGCAAGA CGACAACCGCAUCCGUUCU |
10 |
5 |
5 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2131 |
CUGUUGGCGUAGGCAAGAG GACAACCGCAUCCGUUCUC |
13 |
2 |
11 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2132 |
UGUUGGCGUAGGCAAGAGU ACAACCGCAUCCGUUCUCA |
2 |
15 |
-13 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2133 |
GUUGGCGUAGGCAAGAGUG CAACCGCAUCCGUUCUCAC |
25 |
5 |
20 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2134 |
UUGGCGUAGGCAAGAGUGC AACCGCAUCCGUUCUCACG |
3 |
15 |
-12 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2135 |
UGGCGUAGGCAAGAGUGCC ACCGCAUCCGUUCUCACGG |
75 |
70 |
5 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2136 |
UGGCGUAGGCAAGAGUGCC ACCGCAUCCGUUCUCACGG |
5 |
0 |
5 |
K-RAS (KRAS) |
Cancer |
|
US2005/0176045A1 |
aspsirna2315 |
AGGCAUGUUGGAGACUUGC UCCGUACAACCUCUGAACG |
NA |
NA |
8 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2316 |
GGCAUGUUGGAGACUUGCG CCGUACAACCUCUGAACGC |
NA |
NA |
15 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2317 |
GCAUGUUGGAGACUUGCGC CGUACAACCUCUGAACGCG |
NA |
NA |
20 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2318 |
CAUGUUGGAGACUUGCGCA GUACAACCUCUGAACGCGU |
NA |
NA |
15 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2319 |
AUGUUGGAGACUUGCGCAA UACAACCUCUGAACGCGUU |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2320 |
UGUUGGAGACUUGCGCAAU ACAACCUCUGAACGCGUUA |
NA |
NA |
9 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2321 |
GUUGGAGACUUGCGCAAUG CAACCUCUGAACGCGUUAC |
NA |
NA |
15 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2322 |
UUGGAGACUUGCGCAAUGU AACCUCUGAACGCGUUACA |
NA |
NA |
50 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2323 |
UGGAGACUUGCGCAAUGUG ACCUCUGAACGCGUUACAC |
NA |
NA |
55 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2324 |
GGAGACUUGCGCAAUGUGA CCUCUGAACGCGUUACACU |
NA |
NA |
40 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2325 |
GAGACUUGCGCAAUGUGAC CUCUGAACGCGUUACACUG |
NA |
NA |
35 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2326 |
AGACUUGCGCAAUGUGACU UCUGAACGCGUUACACUGA |
NA |
NA |
20 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2327 |
GACUUGCGCAAUGUGACUG CUGAACGCGUUACACUGAC |
NA |
NA |
65 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2328 |
ACUUGCGCAAUGUGACUGC UGAACGCGUUACACUGACG |
NA |
NA |
55 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2329 |
CUUGCGCAAUGUGACUGCU GAACGCGUUACACUGACGA |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2330 |
UUGCGCAAUGUGACUGCUG AACGCGUUACACUGACGAC |
NA |
NA |
70 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2331 |
UGCGCAAUGUGACUGCUGA ACGCGUUACACUGACGACU |
NA |
NA |
8 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2332 |
GCGCAAUGUGACUGCUGAC CGCGUUACACUGACGACUG |
NA |
NA |
20 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2333 |
CGCAAUGUGACUGCUGACA GCGUUACACUGACGACUGU |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2334 |
GGAGACUUGCGCAAUGUGA CCUCUGAACGCGUUACACU |
75 |
45 |
30 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2335 |
UCACAUUGCGCAAGUCUCC AGUGUAACGCGUUCAGAGG |
45 |
40 |
5 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2336 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGCAAGUCUCC |
82 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2337 |
AGUGUAACGGGUUCAGAGG UCACAUUGCCCAAGUCUCC |
88 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2338 |
AGUGUAACGUGUUCAGAGG UCACAUUGCACAAGUCUCC |
75 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2339 |
AGUGUAACGAGUUCAGAGG UCACAUUGCUCAAGUCUCC |
78 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2340 |
AGUGUAACGAGUUCAGAGG UCACAUUGCCCAAGUCUCC |
75 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2341 |
AGUGUAACGGGUUCAGAGG UCACAUUGCUCAAGUCUCC |
60 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2342 |
AGUGUAACGUGUUCAGAGG UCACAUUGCCCAAGUCUCC |
65 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2343 |
AGUGUAACGUGUUCAGAGG UCACAUUGCUCAAGUCUCC |
50 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2344 |
AGUGUAACGCGUUCAGAGG UCACAUUGCACAAGUCUCC |
42 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2345 |
AGUGUAACGUGUUCAGAGG UCACAUUGCGCAAGUCUCC |
40 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2346 |
AGUGUAACGCGUUCAGAGG UCACAUUGCCCAAGUCUCC |
52 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2347 |
AGUGUAACGCGUUCAGAGG UCACAUUGCUCAAGUCUCC |
35 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2348 |
AGUGUAACGAGUUCAGAGG UCACAUUGCGCAAGUCUCC |
30 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2349 |
AGUGUAACGGGUUCAGAGG UCACAUUGCGCAAGUCUCC |
23 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2350 |
AGUGUAACGAGUUCAGAGG UCACAUUGCACAAGUCUCC |
20 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2351 |
AGUGUAACGGGUUCAGAGG UCACAUUGCACAAGUCUCC |
10 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2352 |
AGUGUAACGAGUUCAGAGG UCACAUUGCUCAAGUCUCC |
80 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2353 |
AGUGUAACGGGUUCAGAGG UCACAUUGCUCAAGUCUCC |
70 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2354 |
AGUGUAACGUGUUCAGAGG UCACAUUGCUCAAGUCUCC |
50 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2355 |
AGUGUAACGCGUUCAGAGG UCACAUUGCUCAAGUCUCC |
45 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2356 |
AGUGUAACGUGUUCAGAGG UCACAUUGCACAAGUCUCC |
86 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2357 |
AGUGUAACGCGUUCAGAGG UCACAUUGCACAAGUCUCC |
50 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2358 |
AGUGUAACGAGUUCAGAGG UCACAUUGCACAAGUCUCC |
20 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2359 |
AGUGUAACGGGUUCAGAGG UCACAUUGCACAAGUCUCC |
10 |
NA |
NA |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2360 |
AGUGUAACGCGUUCAGAGG ACACAUUGCGCAAGUCUCC |
NA |
NA |
82 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2361 |
AGUGUAACGCGUUCAGAGG UAACAUUGCGCAAGUCUCC |
NA |
NA |
45 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2362 |
AGGGUAACGCGUUCAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
60 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2363 |
AGUGUAACGCGUUCAGAGG UCAAAUUGCGCAAGUCUCC |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2364 |
AGUGGAACGCGUUCAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
58 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2365 |
AGUGUAACGCGUUCAGAGG UCACAAUGCGCAAGUCUCC |
NA |
NA |
42 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2366 |
AGUGUAACGCGUUCAGAGG UCACAUAGCGCAAGUCUCC |
NA |
NA |
12 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2367 |
AGUGUAAGGCGUUCAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
75 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2368 |
AGUGUAACGCGUUCAGAGG UCACAUUGAGCAAGUCUCC |
NA |
NA |
25 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2369 |
AGUGUAACGGGUUCAGAGG UCACAUUGCACAAGUCUCC |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2370 |
AGUGUAACGGGUUCAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
30 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2371 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGAAAGUCUCC |
NA |
NA |
43 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2372 |
AGUGUAACGCGGUCAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
58 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2373 |
AGUGUAACGCGUGCAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
30 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2374 |
AGUGUAACGCGUUGAGAGG UCACAUUGCGCAAGUCUCC |
NA |
NA |
80 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2375 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGCAAGACUCC |
NA |
NA |
60 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2376 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGCAAGUAUCC |
NA |
NA |
22 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2377 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGCAAGUCACC |
NA |
NA |
65 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2378 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGCAAGUCUAC |
NA |
NA |
80 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2379 |
AGUGUAACGCGUUCAGAGG UCACAUUGCGCAAGUCUCG |
NA |
NA |
85 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2380 |
ACGCGUUCAGAGGUUGUAC AGCGCAAGUCUCCAACAUG |
NA |
NA |
80 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2381 |
AGGCGUUCAGAGGUUGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
40 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2382 |
ACGCGUUCAGAGGUUGUAC UGGGCAAGUCUCCAACAUG |
NA |
NA |
5 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2383 |
ACGGGUUCAGAGGUUGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
20 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2384 |
ACGCGUUCAGAGGUUGUAC UGCGGAAGUCUCCAACAUG |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2385 |
ACGCGGUCAGAGGUUGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
45 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2386 |
ACGCGUGCAGAGGUUGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
50 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2387 |
ACGCGUUGAGAGGUUGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
40 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2388 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGACUCCAACAUG |
NA |
NA |
38 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2389 |
ACGCGUUCAAAGGUUGUAC UGCGCAAGUAUCCAACAUG |
NA |
NA |
46 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2390 |
ACGCGUUCAAAGGUUGUAC UGCGCAAGUGUCCAACAUG |
NA |
NA |
40 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2391 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGUAUCCAACAUG |
NA |
NA |
75 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2392 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGUCACCAACAUG |
NA |
NA |
23 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2393 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGUCUGCAACAUG |
NA |
NA |
20 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2394 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGUCUCGAACAUG |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2395 |
ACGCGUUCAGAGGGUGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
60 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2396 |
ACGCGUUCAGAGGUGGUAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
65 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2397 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGUCUCCAAGAUG |
NA |
NA |
10 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2398 |
ACGCGUUCAGAGGUUGGAC UGCGCAAGUCUCCAACAUG |
NA |
NA |
70 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2399 |
ACGCGUUCAGAGGUUGUAC UGCGCAAGUCUCCAACAAG |
NA |
NA |
60 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2400 |
ACGCGUUCAGAGGUUGUAG UGCGCAAGUCUCCAACAUG |
NA |
NA |
85 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2401 |
AGUGUAACGGGUUCAGAGG UCACAUUGCCCAAGUAUCC |
NA |
NA |
20 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2402 |
ACGGGUUCAGAGGUUAUAC UGCCCAAGUCUCCAAGAUG |
NA |
NA |
100 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2403 |
GUCGUCAGUGUAACGGGUU CAGCAGUCACAUUGCGCAA |
NA |
NA |
22 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2404 |
UCAGUGUAACGGGUUUAGA AGUCACAUUGCCCAAGUCU |
NA |
NA |
50 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2405 |
GGUUCAGAGGUUGUACGGA CCAAGUCUCCAACAUUCCU |
NA |
NA |
22 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
US2007/0259827A1 |
aspsirna2733 |
ACGGGCAAGGCCAAGUGGG UGCCCGUUCCGGUUCACCC |
NA |
NA |
87 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2734 |
CGGGCAAGGCCAAGUGGGA GCCCGUUCCGGUUCACCCU |
NA |
NA |
88 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2735 |
GGGCAAGGCCAAGUGGGAU CCCGUUCCGGUUCACCCUA |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2736 |
GGCAAGGCCAAGUGGGAUG CCGUUCCGGUUCACCCUAC |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2737 |
GCAAGGCCAAGUGGGAUGC CGUUCCGGUUCACCCUACG |
NA |
NA |
90 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2738 |
CAAGGCCAAGUGGGAUGCC GUUCCGGUUCACCCUACGG |
NA |
NA |
88 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2739 |
AAGGCCAAGUGGGAUGCCU UUCCGGUUCACCCUACGGA |
NA |
NA |
90 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2740 |
AGGCCAAGUGGGAUGCCUG UCCGGUUCACCCUACGGAC |
NA |
NA |
85 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2741 |
GGCCAAGUGGGAUGCCUGG CCGGUUCACCCUACGGACC |
NA |
NA |
85 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2742 |
GCCAAGUGGGAUGCCUGGA CGGUUCACCCUACGGACCU |
NA |
NA |
70 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2743 |
CCAAGUGGGAUGCCUGGAA GGUUCACCCUACGGACCUU |
NA |
NA |
87 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2744 |
CAAGUGGGAUGCCUGGAAU GUUCACCCUACGGACCUUA |
NA |
NA |
86 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2745 |
AAGUGGGAUGCCUGGAAUG UUCACCCUACGGACCUUAC |
NA |
NA |
85 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2746 |
AGUGGGAUGCCUGGAAUGA UCACCCUACGGACCUUACU |
NA |
NA |
88 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2747 |
GUGGGAUGCCUGGAAUGAG CACCCUACGGACCUUACUC |
NA |
NA |
89 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2748 |
UGGGAUGCCUGGAAUGAGC ACCCUACGGACCUUACUCG |
NA |
NA |
90 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2749 |
GGGAUGCCUGGAAUGAGCU CCCUACGGACCUUACUCGA |
NA |
NA |
84 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2750 |
GGAUGCCUGGAAUGAGCUG CCUACGGACCUUACUCGAC |
NA |
NA |
82 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2751 |
GAUGCCUGGAAUGAGCUGA CUACGGACCUUACUCGACU |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2752 |
AUGCCUGGAAUGAGCUGAA UACGGACCUUACUCGACUU |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2753 |
UGCCUGGAAUGAGCUGAAA ACGGACCUUACUCGACUUU |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2754 |
GCCUGGAAUGAGCUGAAAG CGGACCUUACUCGACUUUC |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2755 |
CCUGGAAUGAGCUGAAAGG GGACCUUACUCGACUUUCC |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2756 |
CUGGAAUGAGCUGAAAGGG GACCUUACUCGACUUUCCC |
NA |
NA |
80 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2757 |
UGGAAUGAGCUGAAAGGGA ACCUUACUCGACUUUCCCU |
NA |
NA |
77 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2758 |
GGAAUGAGCUGAAAGGGAC CCUUACUCGACUUUCCCUG |
NA |
NA |
75 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2759 |
GAAUGAGCUGAAAGGGACU CUUACUCGACUUUCCCUGA |
NA |
NA |
70 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2760 |
AAUGAGCUGAAAGGGACUU UUACUCGACUUUCCCUGAA |
NA |
NA |
67 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2761 |
AUGAGCUGAAAGGGACUUC UACUCGACUUUCCCUGAAG |
NA |
NA |
68 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2762 |
UGAGCUGAAAGGGACUUCC ACUCGACUUUCCCUGAAGG |
NA |
NA |
66 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2763 |
GAGCUGAAAGGGACUUCCA CUCGACUUUCCCUGAAGGU |
NA |
NA |
64 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2764 |
AGCUGAAAGGGACUUCCAA UCGACUUUCCCUGAAGGUU |
NA |
NA |
72 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2765 |
GCUGAAAGGGACUUCCAAG CGACUUUCCCUGAAGGUUC |
NA |
NA |
62 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2766 |
CUGAAAGGGACUUCCAAGG GACUUUCCCUGAAGGUUCC |
NA |
NA |
65 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2767 |
UGAAAGGGACUUCCAAGGA ACUUUCCCUGAAGGUUCCU |
NA |
NA |
60 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2768 |
GAAAGGGACUUCCAAGGAA CUUUCCCUGAAGGUUCCUU |
NA |
NA |
67 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2769 |
AAAGGGACUUCCAAGGAAG UUUCCCUGAAGGUUCCUUC |
NA |
NA |
55 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2770 |
AAGGGACUUCCAAGGAAGA UUCCCUGAAGGUUCCUUCU |
NA |
NA |
63 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2771 |
AGGGACUUCCAAGGAAGAU UCCCUGAAGGUUCCUUCUA |
NA |
NA |
65 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2772 |
GGGACUUCCAAGGAAGAUG CCCUGAAGGUUCCUUCUAC |
NA |
NA |
77 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2773 |
GGACUUCCAAGGAAGAUGC CCUGAAGGUUCCUUCUACG |
NA |
NA |
75 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2774 |
GACUUCCAAGGAAGAUGCC CUGAAGGUUCCUUCUACGG |
NA |
NA |
63 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2775 |
ACUUCCAAGGAAGAUGCCA UGAAGGUUCCUUCUACGGU |
NA |
NA |
55 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2776 |
CUUCCAAGGAAGAUGCCAU GAAGGUUCCUUCUACGGUA |
NA |
NA |
67 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2777 |
UUCCAAGGAAGAUGCCAUG AAGGUUCCUUCUACGGUAC |
NA |
NA |
61 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2778 |
UCCAAGGAAGAUGCCAUGA AGGUUCCUUCUACGGUACU |
NA |
NA |
58 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2779 |
CCAAGGAAGAUGCCAUGAA GGUUCCUUCUACGGUACUU |
NA |
NA |
59 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2780 |
CAAGGAAGAUGCCAUGAAA GUUCCUUCUACGGUACUUU |
NA |
NA |
60 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2781 |
AAGGAAGAUGCCAUGAAAG UUCCUUCUACGGUACUUUC |
NA |
NA |
54 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2782 |
AGGAAGAUGCCAUGAAAGC UCCUUCUACGGUACUUUCG |
NA |
NA |
52 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2783 |
GGAAGAUGCCAUGAAAGCU CCUUCUACGGUACUUUCGA |
NA |
NA |
55 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2784 |
GAAGAUGCCAUGAAAGCUU CUUCUACGGUACUUUCGAA |
NA |
NA |
56 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2785 |
AAGAUGCCAUGAAAGCUUA UUCUACGGUACUUUCGAAU |
NA |
NA |
60 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2786 |
AGAUGCCAUGAAAGCUUAC UCUACGGUACUUUCGAAUG |
NA |
NA |
50 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2787 |
GAUGCCAUGAAAGCUUACA CUACGGUACUUUCGAAUGU |
NA |
NA |
54 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2788 |
AUGCCAUGAAAGCUUACAU UACGGUACUUUCGAAUGUA |
NA |
NA |
51 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2789 |
UGCCAUGAAAGCUUACAUC ACGGUACUUUCGAAUGUAG |
NA |
NA |
49 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2790 |
GCCAUGAAAGCUUACAUCA CGGUACUUUCGAAUGUAGU |
NA |
NA |
47 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2791 |
CCAUGAAAGCUUACAUCAA GGUACUUUCGAAUGUAGUU |
NA |
NA |
48 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2792 |
CAUGAAAGCUUACAUCAAC GUACUUUCGAAUGUAGUUG |
NA |
NA |
50 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2793 |
AUGAAAGCUUACAUCAACA UACUUUCGAAUGUAGUUGU |
NA |
NA |
44 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2794 |
UGAAAGCUUACAUCAACAA ACUUUCGAAUGUAGUUGUU |
NA |
NA |
42 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2795 |
GAAAGCUUACAUCAACAAA CUUUCGAAUGUAGUUGUUU |
NA |
NA |
40 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2796 |
AAAGCUUACAUCAACAAAG UUUCGAAUGUAGUUGUUUC |
NA |
NA |
39 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2797 |
AAGCUUACAUCAACAAAGU UUCGAAUGUAGUUGUUUCA |
NA |
NA |
38 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2798 |
AGCUUACAUCAACAAAGUA UCGAAUGUAGUUGUUUCAU |
NA |
NA |
34 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2799 |
GCUUACAUCAACAAAGUAG CGAAUGUAGUUGUUUCAUC |
NA |
NA |
36 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2800 |
CUUACAUCAACAAAGUAGA GAAUGUAGUUGUUUCAUCU |
NA |
NA |
38 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2801 |
UUACAUCAACAAAGUAGAA AAUGUAGUUGUUUCAUCUU |
NA |
NA |
33 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2802 |
UACAUCAACAAAGUAGAAG AUGUAGUUGUUUCAUCUUC |
NA |
NA |
40 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2803 |
ACAUCAACAAAGUAGAAGA UGUAGUUGUUUCAUCUUCU |
NA |
NA |
45 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2804 |
CAUCAACAAAGUAGAAGAG GUAGUUGUUUCAUCUUCUC |
NA |
NA |
42 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2805 |
AUCAACAAAGUAGAAGAGC UAGUUGUUUCAUCUUCUCG |
NA |
NA |
33 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2806 |
UCAACAAAGUAGAAGAGCU AGUUGUUUCAUCUUCUCGA |
NA |
NA |
24 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2807 |
CAACAAAGUAGAAGAGCUA GUUGUUUCAUCUUCUCGAU |
NA |
NA |
27 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2808 |
AACAAAGUAGAAGAGCUAA UUGUUUCAUCUUCUCGAUU |
NA |
NA |
30 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2809 |
ACAAAGUAGAAGAGCUAAA UGUUUCAUCUUCUCGAUUU |
NA |
NA |
25 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2810 |
CAAAGUAGAAGAGCUAAAG GUUUCAUCUUCUCGAUUUC |
NA |
NA |
25 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2811 |
AAAGUAGAAGAGCUAAAGA UUUCAUCUUCUCGAUUUCU |
NA |
NA |
24 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2812 |
AAGUAGAAGAGCUAAAGAA UUCAUCUUCUCGAUUUCUU |
NA |
NA |
30 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2813 |
AGUAGAAGAGCUAAAGAAA UCAUCUUCUCGAUUUCUUU |
NA |
NA |
34 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2814 |
GUAGAAGAGCUAAAGAAAA CAUCUUCUCGAUUUCUUUU |
NA |
NA |
20 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2815 |
UAGAAGAGCUAAAGAAAAA AUCUUCUCGAUUUCUUUUU |
NA |
NA |
10 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2816 |
AGAAGAGCUAAAGAAAAAA UCUUCUCGAUUUCUUUUUU |
NA |
NA |
15 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2817 |
GAAGAGCUAAAGAAAAAAU CUUCUCGAUUUCUUUUUUA |
NA |
NA |
15 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2818 |
AAGAGCUAAAGAAAAAAUA UUCUCGAUUUCUUUUUUAU |
NA |
NA |
20 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2819 |
AGAGCUAAAGAAAAAAUAC UCUCGAUUUCUUUUUUAUG |
NA |
NA |
15 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2820 |
GAGCUAAAGAAAAAAUACG CUCGAUUUCUUUUUUAUGC |
NA |
NA |
11 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2821 |
AGCUAAAGAAAAAAUACGG UCGAUUUCUUUUUUAUGCC |
NA |
NA |
10 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2822 |
GCUAAAGAAAAAAUACGGG CGAUUUCUUUUUUAUGCCC |
NA |
NA |
10 |
Diazepam binding inhibitor (DBI)(GABA receptor modulator, acyl-CoA binding protein) |
NA |
|
US007576197B2 |
aspsirna2939 |
CAUAGUCAUUUCUAAAAGU GUAUCAGUAAAGAUUUUCA |
90 |
20 |
70 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2940 |
CACUAGUAGAAAGUAUAAU GUGAUCAUCUUUCAUAUUA |
85 |
20 |
65 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2941 |
GUAGAAAGUAUAAUUUCAA CAUCUUUCAUAUUAAAGUU |
10 |
20 |
-10 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2942 |
AGUCAUUUCUAAAAGUCAC UCAGUAAAGAUUUUCAGUG |
80 |
20 |
60 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2943 |
UUCUAAAAGUCACUAGUAG AAGAUUUUCAGUGAUCAUC |
80 |
20 |
60 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2944 |
AAAAGUCACUAGUAGAAAG UUUUCAGUGAUCAUCUUUC |
78 |
20 |
58 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2945 |
CAUAGUCAUAUCUAAAAGU GUAUCAGUAUAGAUUUUCA |
30 |
20 |
10 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2946 |
CAUAGUCAUGUCUAAAAGU GUAUCAGUACAGAUUUUCA |
40 |
20 |
20 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2947 |
CACUAGUAGUAAGUAUAAU GUGAUCAUCAUUCAUAUUA |
45 |
20 |
25 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2948 |
CACUAGUAGGAAGUAUAAU GUGAUCAUCCUUCAUAUUA |
50 |
20 |
30 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2949 |
CACUAGUAGCAAGUAUAAU GUGAUCAUCGUUCAUAUUA |
50 |
20 |
30 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2950 |
UUCUAAAAGACACUAGUAG AAGAUUUUCUGUGAUCAUC |
33 |
20 |
13 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2951 |
UUCUAAAAGGCACUAGUAG AAGAUUUUCCGUGAUCAUC |
30 |
20 |
10 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2952 |
GGAUUUAUGUGGAUACAAA CCUAAAUACACCUAUGUUU |
95 |
15 |
80 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2953 |
GAUUUAUGUGGAUACAAAU CUAAAUACACCUAUGUUUA |
96 |
15 |
81 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2954 |
GAUACAAAUUCUCCUUUAAA CUAUGUUUAAGAGGAAAUUU |
98 |
15 |
83 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2955 |
UGUGGAUACAAAUUCUCCU ACACCUAUGUUUAAGAGGA |
90 |
15 |
75 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2956 |
UCCUUUAAAGUGUUUCUUC AGGAAAUUUCACAAAGAAG |
20 |
15 |
5 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2957 |
UUCCCUUAAUAUUUAUCUG AAGGGAAUUAUAAAUAGAC |
20 |
15 |
5 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2958 |
UUUAUGUGGAUACAAAUUC AAAUACACCUAUGUUUAAG |
45 |
15 |
30 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2959 |
UUAUGUGGAUACAAAUUCU AAUACACCUAUGUUUAAGA |
80 |
15 |
65 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2960 |
UAUGUGGAUACAAAUUCUC AUACACCUAUGUUUAAGAG |
55 |
15 |
40 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2961 |
AUGUGGAUACAAAUUCUCC UACACCUAUGUUUAAGAGG |
45 |
15 |
30 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2962 |
UGUGGAUACAAAUUCUCCU ACACCUAUGUUUAAGAGGA |
90 |
15 |
75 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2963 |
GGAUUUAUGAGGAUACAAA CCUAAAUACUCCUAUGUUU |
95 |
15 |
80 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2964 |
GGAUUUAUGGGGAUACAAA CCUAAAUACCCCUAUGUUU |
96 |
15 |
81 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2965 |
CAUAGUCAUUUCUAAAAGU GUAUCAGUAAAGAUUUUCA |
70 |
20 |
50 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2966 |
CACUAGUAGAAAGUAUAAU GUGAUCAUCUUUCAUAUUA |
70 |
20 |
50 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2967 |
GUAGAAAGUAUAAUUUCAA CAUCUUUCAUAUUAAAGUU |
75 |
20 |
55 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2968 |
AGUCAUUUCUAAAAGUCAC UCAGUAAAGAUUUUCAGUG |
40 |
20 |
20 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2969 |
UUCUAAAAGUCACUAGUAG AAGAUUUUCAGUGAUCAUC |
55 |
20 |
35 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2970 |
AAAAGUCACUAGUAGAAAG UUUUCAGUGAUCAUCUUUC |
45 |
20 |
25 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2971 |
CAUAGUCAUAUCUAAAAGU GUAUCAGUAUAGAUUUUCA |
20 |
20 |
0 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2972 |
CAUAGUCAUGUCUAAAAGU GUAUCAGUACAGAUUUUCA |
30 |
20 |
10 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2973 |
CACUAGUAGUAAGUAUAAU GUGAUCAUCAUUCAUAUUA |
38 |
20 |
18 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2974 |
CACUAGUAGGAAGUAUAAU GUGAUCAUCCUUCAUAUUA |
45 |
20 |
25 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2975 |
CACUAGUAGCAAGUAUAAU GUGAUCAUCGUUCAUAUUA |
24 |
20 |
4 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2976 |
UUCUAAAAGACACUAGUAG AAGAUUUUCUGUGAUCAUC |
20 |
20 |
0 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2977 |
UUCUAAAAGGCACUAGUAG AAGAUUUUCCGUGAUCAUC |
25 |
20 |
5 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2978 |
GGAUUUAUGUGGAUACAAA CCUAAAUACACCUAUGUUU |
86 |
15 |
71 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2979 |
GAUUUAUGUGGAUACAAAU CUAAAUACACCUAUGUUUA |
88 |
15 |
73 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2980 |
GAUACAAAUUCUCCUUUAAA CUAUGUUUAAGAGGAAAUUU |
85 |
15 |
70 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2981 |
UGUGGAUACAAAUUCUCCU ACACCUAUGUUUAAGAGGA |
80 |
15 |
65 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2982 |
UCCUUUAAAGUGUUUCUUC AGGAAAUUUCACAAAGAAG |
20 |
15 |
5 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2983 |
UUCCCUUAAUAUUUAUCUG AAGGGAAUUAUAAAUAGAC |
15 |
15 |
0 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2984 |
UUUAUGUGGAUACAAAUUC AAAUACACCUAUGUUUAAG |
50 |
15 |
35 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2985 |
UUAUGUGGAUACAAAUUCU AAUACACCUAUGUUUAAGA |
80 |
15 |
65 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2986 |
UAUGUGGAUACAAAUUCUC AUACACCUAUGUUUAAGAG |
65 |
15 |
50 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2987 |
AUGUGGAUACAAAUUCUCC UACACCUAUGUUUAAGAGG |
20 |
15 |
5 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2988 |
UGUGGAUACAAAUUCUCCU ACACCUAUGUUUAAGAGGA |
75 |
15 |
60 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2989 |
GGAUUUAUGAGGAUACAAA CCUAAAUACUCCUAUGUUU |
80 |
15 |
65 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2990 |
GGAUUUAUGGGGAUACAAA CCUAAAUACCCCUAUGUUU |
76 |
15 |
61 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2991 |
CACUAGUAGUAAGUAUAAU GUGAUCAUCAUUCAUAUUA |
40 |
20 |
20 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna2992 |
UAUGUGGAUACAAAUUCUC AUACACCUAUGUUUAAGAG |
35 |
15 |
20 |
Synuclein, alpha (SNCA) |
Parkinsons disease (PD) |
|
25965551 |
aspsirna3552 |
GUGGCCAGAUGGAAGUAAAAUC CACCGGUCUACCUUCAUUUUAG |
70 |
68 |
2 |
Microtubule-associated protein tau (MAPT) |
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
|
US20080176812A1 |
aspsirna3553 |
GUGGCCACAUGGAAGUAAAAUC CACCGGUGUACCUUCAUUUUAG |
55 |
0 |
55 |
Microtubule-associated protein tau (MAPT) |
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
|
US20080176812A1 |
aspsirna3554 |
GUGGCCAGAUGCAAGUAAAAUC CACCGGUCUACGUUCAUUUUAG |
59 |
10 |
49 |
Microtubule-associated protein tau (MAPT) |
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
|
US20080176812A1 |
aspsirna3555 |
GUGGCCAGAUGGAAGUAAAAUC CACCGGUCUACCUUCAUUUUAG |
70 |
68 |
2 |
Torsin family 1 member A (TOR1A) |
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
|
US20080176812A1 |
aspsirna3556 |
GUGGCCACAUGGAAGUAAAAUC CACCGGUGUACCUUCAUUUUAG |
55 |
0 |
55 |
Torsin family 1 member A (TOR1A) |
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
|
US20080176812A1 |
aspsirna3557 |
GUGGCCAGAUGCAAGUAAAAUC CACCGGUCUACGUUCAUUUUAG |
59 |
10 |
49 |
Torsin family 1 member A (TOR1A) |
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) |
|
US20080176812A1 |
aspsirna3558 |
UGGAGACUUGCGCAAUGUG ACCUCUGAACGCGUUACAC |
80 |
10 |
70 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
EP1567539B1 |
aspsirna3559 |
GGAGACUUGCGCAAUGUGA CCUCUGAACGCGUUACACU |
76 |
12 |
64 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
EP1567539B1 |
aspsirna3560 |
GAGACUUGCGCAAUGUGAC CUCUGAACGCGUUACACUG |
96 |
13 |
83 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
EP1567539B1 |
aspsirna3567 |
GACAAAGAUGCUGUGGCCGAU CUGUUUCUACGACACCGGCUA |
87 |
20 |
67 |
Cu,Zn superoxide dismutase (SOD1) |
Amyotrophic Lateral Sclerosis (ALS) |
|
EP1567539B1 |
aspsirna3577 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3578 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUA |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3579 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUC |
90 |
45 |
45 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3580 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUG |
90 |
35 |
55 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3581 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3582 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUAU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3583 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUCU |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3584 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUGU |
90 |
42 |
48 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3585 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3586 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAAUU |
90 |
42 |
48 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3587 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUACUU |
90 |
55 |
35 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3588 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAGUU |
90 |
65 |
25 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3589 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3590 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUCUUU |
90 |
79 |
11 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3591 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUGUUU |
90 |
72 |
18 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3592 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUUUUU |
90 |
84 |
6 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3593 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3594 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGAAUUU |
90 |
75 |
15 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3595 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGCAUUU |
90 |
88 |
2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3596 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGGAUUU |
90 |
65 |
25 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3597 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3598 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAAUAUUU |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3599 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGACUAUUU |
90 |
72 |
18 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3600 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAUUAUUU |
90 |
78 |
12 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3601 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3602 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGCGUAUUU |
90 |
75 |
15 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3603 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGGGUAUUU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3604 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGUGUAUUU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3605 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3606 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGAAGUAUUU |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3607 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGCAGUAUUU |
90 |
62 |
28 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3608 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGUAGUAUUU |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3609 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3610 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAAGAGUAUUU |
90 |
49 |
41 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3611 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUACGAGUAUUU |
90 |
55 |
35 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3612 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAUGAGUAUUU |
90 |
60 |
30 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3613 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3614 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUCGGAGUAUUU |
90 |
50 |
40 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3615 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUGGGAGUAUUU |
90 |
8 |
82 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3616 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUUGGAGUAUUU |
90 |
12 |
78 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3617 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3618 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCAAGGAGUAUUU |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3619 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCCAGGAGUAUUU |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3620 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCGAGGAGUAUUU |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3621 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3622 |
UCAGAGAGAUCCUCAUAAA AGUCUCUAUAGGAGUAUUU |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3623 |
UCAGAGAGAUCCUCAUAAA AGUCUCUGUAGGAGUAUUU |
90 |
28 |
62 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3624 |
UCAGAGAGAUCCUCAUAAA AGUCUCUUUAGGAGUAUUU |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3625 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3626 |
UCAGAGAGAUCCUCAUAAA AGUCUCACUAGGAGUAUUU |
90 |
69 |
21 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3627 |
UCAGAGAGAUCCUCAUAAA AGUCUCCCUAGGAGUAUUU |
90 |
62 |
28 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3628 |
UCAGAGAGAUCCUCAUAAA AGUCUCGCUAGGAGUAUUU |
90 |
67 |
23 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3629 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3630 |
UCAGAGAGAUCCUCAUAAA AGUCUAUCUAGGAGUAUUU |
90 |
32 |
58 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3631 |
UCAGAGAGAUCCUCAUAAA AGUCUGUCUAGGAGUAUUU |
90 |
40 |
50 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3632 |
UCAGAGAGAUCCUCAUAAA AGUCUUUCUAGGAGUAUUU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3633 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3634 |
UCAGAGAGAUCCUCAUAAA AGUCACUCUAGGAGUAUUU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3635 |
UCAGAGAGAUCCUCAUAAA AGUCCCUCUAGGAGUAUUU |
90 |
81 |
9 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3636 |
UCAGAGAGAUCCUCAUAAA AGUCGCUCUAGGAGUAUUU |
90 |
88 |
2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3637 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3638 |
UCAGAGAGAUCCUCAUAAA AGUAUCUCUAGGAGUAUUU |
90 |
49 |
41 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3639 |
UCAGAGAGAUCCUCAUAAA AGUGUCUCUAGGAGUAUUU |
90 |
45 |
45 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3640 |
UCAGAGAGAUCCUCAUAAA AGUUUCUCUAGGAGUAUUU |
90 |
30 |
60 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3641 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3642 |
UCAGAGAGAUCCUCAUAAA AGACUCUCUAGGAGUAUUU |
90 |
72 |
18 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3643 |
UCAGAGAGAUCCUCAUAAA AGCCUCUCUAGGAGUAUUU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3644 |
UCAGAGAGAUCCUCAUAAA AGGCUCUCUAGGAGUAUUU |
90 |
81 |
9 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3645 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3646 |
UCAGAGAGAUCCUCAUAAA AAUCUCUCUAGGAGUAUUU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3647 |
UCAGAGAGAUCCUCAUAAA ACUCUCUCUAGGAGUAUUU |
90 |
90 |
0 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3648 |
UCAGAGAGAUCCUCAUAAA AUUCUCUCUAGGAGUAUUU |
90 |
87 |
3 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3649 |
UCAGAGAGAUCCUCAUAAA AGUCUCUCUAGGAGUAUUU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3650 |
UCAGAGAGAUCCUCAUAAA CGUCUCUCUAGGAGUAUUU |
90 |
95 |
-5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3651 |
UCAGAGAGAUCCUCAUAAA GGUCUCUCUAGGAGUAUUU |
90 |
95 |
-5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3652 |
UCAGAGAGAUCCUCAUAAA UGUCUCUCUAGGAGUAUUU |
90 |
95 |
-5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3653 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3654 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAA |
90 |
97 |
-7 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3655 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAC |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3656 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAG |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3657 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3658 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUCU |
90 |
93 |
-3 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3659 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUGU |
90 |
83 |
7 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3660 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUUU |
90 |
80 |
10 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3661 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3662 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACAAU |
90 |
22 |
68 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3663 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACCAU |
90 |
75 |
15 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3664 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACGAU |
90 |
28 |
62 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3665 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3666 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUAAUAU |
90 |
58 |
32 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3667 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUAGUAU |
90 |
61 |
29 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3668 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUAUUAU |
90 |
71 |
19 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3669 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3670 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUCCUAU |
90 |
90 |
0 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3671 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUGCUAU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3672 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUUCUAU |
90 |
91 |
-1 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3673 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3674 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCAACUAU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3675 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCCACUAU |
90 |
79 |
11 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3676 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCGACUAU |
90 |
90 |
0 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3677 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3678 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUAUACUAU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3679 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUGUACUAU |
90 |
80 |
10 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3680 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUUUACUAU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3681 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3682 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCACUACUAU |
90 |
62 |
28 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3683 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCCCUACUAU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3684 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCGCUACUAU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3685 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3686 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUAUCUACUAU |
90 |
6 |
84 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3687 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUGUCUACUAU |
90 |
28 |
62 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3688 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUUUCUACUAU |
90 |
59 |
31 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3689 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3690 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCACUCUACUAU |
90 |
22 |
68 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3691 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCCCUCUACUAU |
90 |
75 |
15 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3692 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCGCUCUACUAU |
90 |
40 |
50 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3693 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3694 |
GGUUGGAGGAGAGAUGAUA CCAACCUCAUCUCUACUAU |
90 |
53 |
37 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3695 |
GGUUGGAGGAGAGAUGAUA CCAACCUCGUCUCUACUAU |
90 |
40 |
50 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3696 |
GGUUGGAGGAGAGAUGAUA CCAACCUCUUCUCUACUAU |
90 |
35 |
55 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3697 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3698 |
GGUUGGAGGAGAGAUGAUA CCAACCUACUCUCUACUAU |
90 |
55 |
35 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3699 |
GGUUGGAGGAGAGAUGAUA CCAACCUGCUCUCUACUAU |
90 |
72 |
18 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3700 |
GGUUGGAGGAGAGAUGAUA CCAACCUUCUCUCUACUAU |
90 |
80 |
10 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3701 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3702 |
GGUUGGAGGAGAGAUGAUA CCAACCACCUCUCUACUAU |
90 |
64 |
26 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3703 |
GGUUGGAGGAGAGAUGAUA CCAACCCCCUCUCUACUAU |
90 |
73 |
17 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3704 |
GGUUGGAGGAGAGAUGAUA CCAACCGCCUCUCUACUAU |
90 |
78 |
12 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3705 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3706 |
GGUUGGAGGAGAGAUGAUA CCAACAUCCUCUCUACUAU |
90 |
89 |
1 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3707 |
GGUUGGAGGAGAGAUGAUA CCAACGUCCUCUCUACUAU |
90 |
85 |
5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3708 |
GGUUGGAGGAGAGAUGAUA CCAACUUCCUCUCUACUAU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3709 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3710 |
GGUUGGAGGAGAGAUGAUA CCAAACUCCUCUCUACUAU |
90 |
90 |
0 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3711 |
GGUUGGAGGAGAGAUGAUA CCAAGCUCCUCUCUACUAU |
90 |
19 |
71 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3712 |
GGUUGGAGGAGAGAUGAUA CCAAUCUCCUCUCUACUAU |
90 |
54 |
36 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3713 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3714 |
GGUUGGAGGAGAGAUGAUA CCACCCUCCUCUCUACUAU |
90 |
78 |
12 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3715 |
GGUUGGAGGAGAGAUGAUA CCAGCCUCCUCUCUACUAU |
90 |
88 |
2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3716 |
GGUUGGAGGAGAGAUGAUA CCAUCCUCCUCUCUACUAU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3717 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3718 |
GGUUGGAGGAGAGAUGAUA CCCACCUCCUCUCUACUAU |
90 |
95 |
-5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3719 |
GGUUGGAGGAGAGAUGAUA CCGACCUCCUCUCUACUAU |
90 |
93 |
-3 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3720 |
GGUUGGAGGAGAGAUGAUA CCUACCUCCUCUCUACUAU |
90 |
91 |
-1 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3721 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3722 |
GGUUGGAGGAGAGAUGAUA CAAACCUCCUCUCUACUAU |
90 |
93 |
-3 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3723 |
GGUUGGAGGAGAGAUGAUA CGAACCUCCUCUCUACUAU |
90 |
95 |
-5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3724 |
GGUUGGAGGAGAGAUGAUA CUAACCUCCUCUCUACUAU |
90 |
92 |
-2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3725 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3726 |
GGUUGGAGGAGAGAUGAUA ACAACCUCCUCUCUACUAU |
90 |
90 |
0 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3727 |
GGUUGGAGGAGAGAUGAUA GCAACCUCCUCUCUACUAU |
90 |
95 |
-5 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3728 |
GGUUGGAGGAGAGAUGAUA UCAACCUCCUCUCUACUAU |
90 |
93 |
-3 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3729 |
GGUUGGAGGAGAGAUGAUA CCAACCUCCUCUCUACUAU |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3730 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3731 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAC |
90 |
66 |
24 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3732 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAG |
90 |
60 |
30 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3733 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAU |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3734 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3735 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCCA |
90 |
70 |
20 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3736 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCGA |
90 |
38 |
52 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3737 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCUA |
90 |
50 |
40 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3738 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3739 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUAAA |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3740 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUGAA |
90 |
8 |
82 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3741 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUUAA |
90 |
45 |
45 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3742 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3743 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCACAA |
90 |
33 |
57 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3744 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCCCAA |
90 |
50 |
40 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3745 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCGCAA |
90 |
38 |
52 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3746 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3747 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCAUCAA |
90 |
3 |
87 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3748 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCGUCAA |
90 |
18 |
72 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3749 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCUUCAA |
90 |
42 |
48 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3750 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3751 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUACUCAA |
90 |
38 |
52 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3752 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUGCUCAA |
90 |
35 |
55 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3753 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUUCUCAA |
90 |
8 |
82 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3754 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3755 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCACCUCAA |
90 |
48 |
42 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3756 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCCCCUCAA |
90 |
54 |
36 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3757 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCGCCUCAA |
90 |
55 |
35 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3758 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3759 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCAUCCUCAA |
90 |
25 |
65 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3760 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCGUCCUCAA |
90 |
40 |
50 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3761 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCUUCCUCAA |
90 |
76 |
14 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3762 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3763 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGACUCCUCAA |
90 |
6 |
84 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3764 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGGCCUCCUCAA |
90 |
5 |
85 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3765 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGUCUCCUCAA |
90 |
33 |
57 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3766 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3767 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCACCUCCUCAA |
90 |
70 |
20 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3768 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCCCCUCCUCAA |
90 |
38 |
52 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3769 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCUCCUCCUCAA |
90 |
58 |
32 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3770 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3771 |
AAAGUUGCGCGGAGGAGUU UUUCAACGAGCCUCCUCAA |
90 |
22 |
68 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3772 |
AAAGUUGCGCGGAGGAGUU UUUCAACGGGCCUCCUCAA |
90 |
45 |
45 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3773 |
AAAGUUGCGCGGAGGAGUU UUUCAACGUGCCUCCUCAA |
90 |
61 |
29 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3774 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3775 |
AAAGUUGCGCGGAGGAGUU UUUCAACACGCCUCCUCAA |
90 |
45 |
45 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3776 |
AAAGUUGCGCGGAGGAGUU UUUCAACCCGCCUCCUCAA |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3777 |
AAAGUUGCGCGGAGGAGUU UUUCAACUCGCCUCCUCAA |
90 |
42 |
48 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3778 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3779 |
AAAGUUGCGCGGAGGAGUU UUUCAAAGCGCCUCCUCAA |
90 |
0 |
90 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3780 |
AAAGUUGCGCGGAGGAGUU UUUCAAGGCGCCUCCUCAA |
90 |
25 |
65 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3781 |
AAAGUUGCGCGGAGGAGUU UUUCAAUGCGCCUCCUCAA |
90 |
20 |
70 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3782 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3783 |
AAAGUUGCGCGGAGGAGUU UUUCACCGCGCCUCCUCAA |
90 |
46 |
44 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3784 |
AAAGUUGCGCGGAGGAGUU UUUCAGCGCGCCUCCUCAA |
90 |
49 |
41 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3785 |
AAAGUUGCGCGGAGGAGUU UUUCAUCGCGCCUCCUCAA |
90 |
82 |
8 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3786 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3787 |
AAAGUUGCGCGGAGGAGUU UUUCCACGCGCCUCCUCAA |
90 |
55 |
35 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3788 |
AAAGUUGCGCGGAGGAGUU UUUCGACGCGCCUCCUCAA |
90 |
72 |
18 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3789 |
AAAGUUGCGCGGAGGAGUU UUUCUACGCGCCUCCUCAA |
90 |
33 |
57 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3790 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3791 |
AAAGUUGCGCGGAGGAGUU UUUAAACGCGCCUCCUCAA |
90 |
22 |
68 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3792 |
AAAGUUGCGCGGAGGAGUU UUUGAACGCGCCUCCUCAA |
90 |
43 |
47 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3793 |
AAAGUUGCGCGGAGGAGUU UUUUAACGCGCCUCCUCAA |
90 |
46 |
44 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3794 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3795 |
AAAGUUGCGCGGAGGAGUU UUACAACGCGCCUCCUCAA |
90 |
72 |
18 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3796 |
AAAGUUGCGCGGAGGAGUU UUCCAACGCGCCUCCUCAA |
90 |
80 |
10 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3797 |
AAAGUUGCGCGGAGGAGUU UUGCAACGCGCCUCCUCAA |
90 |
75 |
15 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3798 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3799 |
AAAGUUGCGCGGAGGAGUU UAUCAACGCGCCUCCUCAA |
90 |
86 |
4 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3800 |
AAAGUUGCGCGGAGGAGUU UCUCAACGCGCCUCCUCAA |
90 |
88 |
2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3801 |
AAAGUUGCGCGGAGGAGUU UGUCAACGCGCCUCCUCAA |
90 |
89 |
1 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3802 |
AAAGUUGCGCGGAGGAGUU UUUCAACGCGCCUCCUCAA |
90 |
NA |
NA |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3803 |
AAAGUUGCGCGGAGGAGUU AUUCAACGCGCCUCCUCAA |
90 |
80 |
10 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3804 |
AAAGUUGCGCGGAGGAGUU CUUCAACGCGCCUCCUCAA |
90 |
88 |
2 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |
aspsirna3805 |
AAAGUUGCGCGGAGGAGUU GUUCAACGCGCCUCCUCAA |
90 |
90 |
0 |
Peptidylprolyl isomerase B (PPIB)/Cyclophilin B |
PPIB-Related Osteogenesis Imperfecta (Type IX) |
|
16489337 |